Intelligence Β· Clinical Pipeline

Chongqing Precision Biotech Pipeline

All ClinicalTrials.gov programs at Chongqing Precision Biotech β€” phase, modality, and trial IDs.

Programs
49

Quick answer

Chongqing Precision Biotech has 49 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. ​​A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants​

    Chongqing Precision Biotech Co., Ltd

    Epilepsy

    phase 1 other active

    1 trial

Frequently asked questions

How many pipeline programs does Chongqing Precision Biotech have?

49 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs